Nicole Grimm

Nicole Grimm currently serves as the Director of Patent Counsel at Alnylam Pharmaceuticals, a position held since June 2023. Prior experience includes serving as Senior Counsel II for Intellectual Property at Kite Pharma from April 2022 to June 2023 and as a Partner at McDonnell Boehnen Hulbert & Berghoff LLP from September 2012 to April 2022, where the focus was on intellectual property matters, including patent, trademark, and copyright issues. Earlier roles include Associate at McDonnell Boehnen Hulbert & Berghoff LLP, Summer Associate, and Judicial Intern. Educational qualifications include a J.D. from the University of Maryland Francis King Carey School of Law, an M.S. in Biochemistry from the University of Colorado Boulder, and a B.A. in Biochemistry from McDaniel College.